skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical exceeds 1 trillion KRW in 2018 to reset the record.
Date 2019-03-06 Hit 959
News List
Prev Daewoong Pharmaceutical has completed the lineup of hypertension medications with the approval of ‘Olomax.’
Next Daewoong Pharmaceutical has released ‘Olomax’ for both hypertension and hyperlipidemia